M C Dalakas
Overview
Explore the profile of M C Dalakas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
244
Citations
5039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kampylafka E, Alexopoulos H, Fouka P, Moutsopoulos H, Dalakas M, Tzioufas A
Lupus
. 2016 Mar;
25(11):1260-5.
PMID: 26923281
We investigated systemic lupus erythematosus (SLE) patients with epilepsy, a major and organic neurological symptom. Our aim was to test patients for the autoimmune epilepsy-associated antibodies anti-GAD, anti-NMDAR, anti-AMPAR1/2, anti-GABABR...
2.
Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis P, Dalakas M
J Neuroimmunol
. 2015 Apr;
281:73-7.
PMID: 25867471
Antibodies against Glutamic-acid-decarboxylase (GAD65) are seen in various CNS excitability disorders including stiff-person syndrome, cerebellar ataxia, encephalitis and epilepsy. To explore pathogenicity, we examined whether distinct epitope specificities or other...
3.
Dalakas M, Loscher W
Clin Exp Immunol
. 2014 Dec;
178 Suppl 1:138.
PMID: 25546795
The research presented in this section explores novel applications of immunoglobulin (Ig) therapy in neurological disorders. The results from the upcoming and ongoing trials of Drs Honnorat and Gamez are...
4.
Dalakas M, Loscher W
Clin Exp Immunol
. 2014 Dec;
178 Suppl 1:124-6.
PMID: 25546789
The Interlaken Leadership Awards (ILAs), established in 2010, are monetary grants pledged annually by CSL Behring to fund research into the use of immunoglobulin (Ig) therapy, especially into its use...
5.
Alexopoulos H, Kampylafka E, Chatzi I, Travasarou M, Karageorgiou K, Dalakas M, et al.
J Neuroimmunol
. 2013 May;
260(1-2):117-20.
PMID: 23673145
Autoantibodies against the water channel AQP4, expressed predominately in central nervous system astrocytes, are markers and pathogenic factors in Devic's disease. In this study we examined whether Multiple Sclerosis (MS)...
6.
Vanhoutte E, Latov N, Deng C, Hanna K, Hughes R, Bril V, et al.
Eur J Neurol
. 2012 Aug;
20(5):748-55.
PMID: 22891893
Background And Purpose: In a recent trial in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), the ICE study, grip strength measurement captured significantly more improvement in patients receiving immune globulin...
7.
Pavlakis P, Alexopoulos H, Kosmidis M, Mamali I, Moutsopoulos H, Tzioufas A, et al.
J Autoimmun
. 2012 Feb;
39(1-2):27-33.
PMID: 22318209
Sjögren's syndrome is a systemic autoimmune disease that, apart from exocrine glands, may affect every organ or system. Involvement of different sections of the peripheral nervous system results in a...
8.
Kampylafka E, Routsias J, Alexopoulos H, Dalakas M, Moutsopoulos H, Tzioufas A
J Autoimmun
. 2011 Feb;
36(3-4):221-7.
PMID: 21333492
The autoantibody to aquaporin-4 (AQP4) is a marker and a pathogenetic factor in Neuromyelitis Optica (NMO) (Devic's syndrome). Our aim was to identify B-cell antigenic linear epitopes of the AQP4...
9.
Dalakas M
Neuropathol Appl Neurobiol
. 2010 Dec;
37(3):226-42.
PMID: 21155862
The review provides an update on the diagnosis of the main subtypes of inflammatory myopathies including dermatomyositis (DM), polymyositis (PM), necrotizing autoimmune myositis (NAM) and sporadic inclusion body myositis (sIBM)....
10.
Hughes R, Dalakas M, Cornblath D, Latov N, Weksler M, Relkin N
Clin Exp Immunol
. 2009 Nov;
158 Suppl 1:34-42.
PMID: 19883422
Intravenous immunoglobulin (IVIg) is used increasingly in the management of patients with neurological conditions. The efficacy and safety of IVIg treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and Guillain-Barré syndrome...